Expertise in
5
conditions

Masanobu Takahashi

Sendai, JP 
Expertise in
5
conditions
Sendai, JP 

Overview

Masanobu Takahashi practices practicing medicine in Sendai, Japan.

Mr. Takahashi is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Esophageal Cancer, Agranulocytosis, Pancreaticoduodenectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 135 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Sendai, Japan
Other Locations
Yamagata, Japan
Japan
Tohoku, Japan
Osaka, 5320003, Japan
Saitama, 3510198, Japan
Maebashi, 3710816, Japan
Shibuya, 1508938, Japan
Tokyo, Japan
Sapporo, Japan
Nagaoka, 9402188, Japan
St Marianna University Of Medicine, Kawasaki, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer
A Randomized, Double-Blind, Phase III Study Comparing FTD/TPI Therapy Versus Placebo in Patients Who Are Positive for Blood Circulating Tumor DNA After Curative Resection of Colorectal Cancer
Enrollment Status: Completed
Publish Date: January 21, 2026
Intervention Type: Drug
Study Drugs: Trifluridine, Tipiracil
Study Phase: Phase 3

135 Total Publications

SMARCB1/INI1-deficient Undifferentiated Carcinoma Presenting as Cancer of Unknown Primary with Massive Hepatic Involvement: Transient Response to FOLFOX plus Nivolumab.
SMARCB1/INI1-deficient Undifferentiated Carcinoma Presenting as Cancer of Unknown Primary with Massive Hepatic Involvement: Transient Response to FOLFOX plus Nivolumab.
Journal: Internal medicine (Tokyo, Japan)
Published: August 10, 2026

Frequently Asked Questions about Masanobu Takahashi

Is Masanobu Takahashi a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Masanobu Takahashi is classified as an Distinguished expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Masanobu Takahashi participate in research or clinical trials?

Yes. Masanobu Takahashi has published 135 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Masanobu Takahashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Takahashi's expertise for a condition
ConditionClose
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile